RAF1 kinase activity is dispensable for KRAS/p53 mutant lung tumor progression
Manuel Sanclemente, Patricia Nieto, Sara García‐Alonso, Fernando Fernández-García, Laura Esteban-Burgos, Carmen Guerra, Matthias Drosten, Eduardo Caleiras, Jorge L. Martı́nez-Torrecuadrada, David Santamarı́a, Mónica Musteanu, Mariano Barbacid
Topics & Concepts
KRASMutantCancer researchKinaseMutationBiologyCell biologyGeneGeneticsProtein Degradation and InhibitorsUbiquitin and proteasome pathwaysMelanoma and MAPK Pathways